Satışların Fiyatı Değişiklik Tarih
AbbVie USD 4.22B 329M 2026-03
Agenus USD 642K 399K 2025-09
Amgen USD 1.6B 187M 2026-03
Bristol-Myers Squibb USD 3.86B 1.07B 2026-03
Celldex Therapeutics USD 54.2M 8.94M 2025-06
Glaxosmithkline GBP 3.47B 461.37M 2025-12
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Pfizer USD 4.59B 1.7B 2026-03
Rigel Pharmaceuticals USD 8.03M 5.22M 2024-09
Roche Holding CHF 8.48B 4.61B 2025-12